Multiple imaging and excellent anticancer efficiency of an upconverting nanocarrier mediated by single near infrared light

Current Challenges and Opportunities of Photodynamic Therapy against Cancer

BACKGROUND

Photodynamic therapy (PDT) is an established, minimally invasive treatment for specific types of cancer. During PDT, reactive oxygen species (ROS) are generated that ultimately induce cell death and disruption of the tumor area. Moreover, PDT can result in damage to the tumor vasculature and induce the release and/or exposure of damage-associated molecular patterns (DAMPs) that may initiate an antitumor immune response. However, there are currently several challenges of PDT that limit its widespread application for certain indications in the clinic.

METHODS

A literature study was conducted to comprehensively discuss these challenges and to identify opportunities for improvement.

RESULTS

The most notable challenges of PDT and opportunities to improve them have been identified and discussed.

CONCLUSIONS

The recent efforts to improve the current challenges of PDT are promising, most notably those that focus on enhancing immune responses initiated by the treatment. The application of these improvements has the potential to enhance the antitumor efficacy of PDT, thereby broadening its potential application in the clinic.

The Coming of Age of Neodymium: Redefining Its Role in Rare Earth Doped Nanoparticles

Among luminescent nanostructures actively investigated in the last couple of decades, rare earth (RE³⁺) doped nanoparticles (RENPs) are some of the most reported family of materials. The development of RENPs in the biomedical framework is quickly making its transition to the ∼800 nm excitation pathway, beneficial for both in vitro and in vivo applications to eliminate heating and facilitate higher penetration in tissues. Therefore, reports and investigations on RENPs containing the neodymium ion (Nd³⁺) greatly increased in number as the focus on ∼800 nm radiation absorbing Nd³⁺ ion gained traction. In this review, we cover the basics behind the RE³⁺ luminescence, the most successful Nd³⁺-RENP architectures, and highlight application areas. Nd³⁺-RENPs, particularly Nd³⁺-sensitized RENPs, have been scrutinized by considering the division between their upconversion and downshifting emissions. Aside from their distinctive optical properties, significant attention is paid to the diverse applications of Nd³⁺-RENPs, notwithstanding the pitfalls that are still to be addressed. Overall, we aim to provide a comprehensive overview on Nd³⁺-RENPs, discussing their developmental and applicative successes as well as challenges. We also assess future research pathways and foreseeable obstacles ahead, in a field, which we believe will continue witnessing an effervescent progress in the years to come.

Bioimaging with Upconversion Nanoparticles

Bioimaging enables the spatiotemporal visualization of biological processes at various scales empowered by a range of different imaging modalities and contrast agents. Upconversion nanoparticles (UCNPs) represent a distinct type of such contrast agents with the potential to transform bioimaging due to their unique optical properties and functional design flexibilities. This review explores and discusses the opportunities, challenges, and limitations that UCNPs exhibit as bioimaging probes and highlights applications with spatial dimensions ranging from the single nanoparticle level to cellular, tissue, and whole animal imaging. We further summarized recent advancements in bioimaging applications enabled by UCNPs, including super-resolution techniques and multimodal imaging methods, and provide a perspective on the future potential of UCNP-based technologies in bioimaging research and clinical translation. This review may provide a valuable resource for researchers interested in exploring and applying UCNP-based bioimaging technologies.

Effect of the Silica-Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption

A series of new composite materials based on Fe3O4 magnetic nanoparticles coated with SiO2 (or aminated SiO2) were synthesized. It has been shown that the use of N-(phosphonomethyl)iminodiacetic acid (PMIDA) to stabilize nanoparticles before silanization ensures the increased content of a SiO2 phase in the Fe3O4@SiO2 nanocomposites (NCs) in comparison with materials obtained under similar conditions, but without PMIDA. It has been demonstrated for the first time that the presence of PMIDA on the surface of NCs increases the level of Dox loading due to specific binding, while surface modification with 3-aminopropylsilane, on the contrary, significantly reduces the sorption capacity of materials. These regularities were in accordance with the results of quantum chemical calculations. It has been shown that the energies of Dox binding to the functional groups of NCs are in good agreement with the experimental data on the Dox sorption on these NCs. The mechanisms of Dox binding to the surface of NCs were proposed: simultaneous coordination of Dox on the PMIDA molecule and silanol groups at the NC surface leads to a synergistic effect in Dox binding. The synthesized NCs exhibited pH-dependent Dox release, as well as dose-dependent cytotoxicity in in vitro experiments. The cytotoxic effects of the studied materials correspond to their calculated IC50 values. NCs with a SiO2 shell obtained using PMIDA exhibited the highest effect. At the same time, the presence of PMIDA in NCs makes it possible to increase the Dox loading, as well as to reduce its desorption rate, which may be useful in the design of drug delivery vehicles with a prolonged action. We believe that the data obtained can be further used to develop stimuli-responsive materials for targeted cancer chemotherapy.

Upconversion, MRI imaging and optical trapping studies of silver nanoparticle decorated multifunctional NaGdF4:Yb,Er nanocomposite

The multifunctional upconversion nanoparticles (UCNPs) are fascinating tool for biological applications. In the present work, photon upconverting NaGdF₄:Yb,Er and Ag nanoparticles decorated NaGdF₄:Yb,Er (NaGdF₄:Yb,Er@Ag) nanoparticles were prepared using a simple polyol process. Rietveld refinement was performed for detailed crystal structural and phase fraction analysis. The morphology of the NaGdF₄:Yb,Er@Ag was examined using high-resolution transmission electron microscope, which reveals silver nanoparticles of 8 nm in size were decorated over spherical shaped NaGdF₄:Yb,Er nanoparticles with a mean particle size of 90 nm. The chemical compositions were confirmed by EDAX and inductively coupled plasma-optical emission spectrometry analyses. The upconversion luminescence (UCL) of NaGdF₄:Yb,Er at 980 nm excitation showed an intense red emission. After incorporating the silver nanoparticles, the UCL intensity decreased due to weak scattering and surface plasmon resonance effect. The VSM magnetic measurement indicates both the UCNPs possess paramagnetic behaviour. The NaGdF₄:Yb,Er@Ag showed computed tomography imaging. Magnetic resonance imaging study exhibited better T1 weighted relaxivity in the NaGdF₄:Yb,Er than the commercial Gd-DOTA. For the first time, the optical trapping was successfully demonstrated for the upconversion NaGdF₄:Yb,Er nanoparticle at near-infrared 980 nm light using an optical tweezer setup. The optically trapped UCNP possessing paramagnetic property exhibited a good optical trapping stiffness. The UCL of trapped single UCNP is recorded to explore the effect of the silver nanoparticles. The multifunctional properties for the NaGdF₄:Yb,Er@Ag nanoparticle are demonstrated.

NaGdF4:Yb,Er-Ag nanowire hybrid nanocomposite for multifunctional upconversion emission, optical imaging, MRI and CT imaging applications

The effect of novel silver nanowire encapsulated NaGdF₄:Yb,Er hybrid nanocomposite on the upconversion emission and bioimaging properties has been investigated. The upconvension nanomaterials were synthesised by polyol method in the presence of ethylene glycol, PVP and ethylenediamine. The NaGdF₄:Yb,Er-Ag hybrid was formed with upconverting NaGdF₄:Yb,Er nanoparticles of size ~ 80 nm and silver nanowires of thickness ~ 30 nm. The surface plasmon induced by the silver ion in the NaGdF₄:Yb,Er-Ag nanocomposite resulted an intense upconversion green emission at 520 nm and red emission at 660 nm by NIR diode laser excitation at 980 nm wavelength. The UV-Vis-NIR spectral absorption at 440 nm and 980 nm, the intense Raman vibrational modes and the strong upconversion emission results altogether confirm the localised surface plasmon resonance effect of silver ion in the hybrid nanocomposite. MRI study of both NaGdF₄:Yb,Er nanoparticle and NaGdF₄:Yb,Er-Ag nanocomposite revealed the T1 relaxivities of 22.13 and 10.39 mM^-1 s^-1, which are larger than the commercial Gd-DOTA contrast agent of 3.08 mM^-1 s^-1. CT imaging NaGdF₄:Yb,Er-Ag and NaGdF₄:Yb,Er respectively showed the values of 53.29 HU L/g and 39.51 HU L/g, which are higher than 25.78 HU L/g of the CT contrast agent Iobitridol. The NaGdF₄:Yb,Er and NaGdF₄:Yb,Er-Ag respectively demonstrated a negative zeta potential of 54 mV and 55 mV, that could be useful for biological application. The in vitro cytotoxicity of the NaGdF₄:Yb,Er tested in HeLa and MCF-7 cancer cell line by MTT assay demonstrated a cell viability of 90 and 80 %, respectively. But, the cell viability of NaGdF₄:Yb,Er-Ag slightly decreased to 80 and 78%. The confocal microscopy imaging showed that the UCNPs are effectively up-taken inside the nucleolus of the cancer cells, and it might be useful for NIR laser-assisted phototherapy for cancer treatment. Graphical abstract.

One-pot synthesis of theranostic nanocapsules with lanthanide doped nanoparticles

One-pot synthesis of theranostic nanocapsules with lanthanide doped nanoparticles via interfacial templating condensation for upconversion based photodynamic therapy.

Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro

Currently, the nanocomposites based on silicon nanoparticles (SiNPs) are usually limited to a single therapeutic modality, and the design of the SiNPs nanohybrids with multi-modal synergistic therapeutic functions is still worth being explored to achieve more effective treatment. Herein, we used mesoporous silica nanoparticle (MSN) as a nanoplatform, SiNPs and the photosensitizer 5,10,15,20-tetrakis (1-methyl 4-pyridinio) porphyrin tetra (p-toluenesulfonate) (TMPyP) were first embedded in the MSN and was further modified with folic acid (FA) to obtain the mesoporous silica nanocomposite (MSN@SiNPs@TMPyP-FA) for targeted two-photon-excited fluorescence imaging-guided photodynamic therapy (PDT) and chemotherapy. The embedded TMPyP could generate singlet oxygen to perform PDT under light irradiation, meanwhile the anticancer drugs doxorubicin (DOX) could be loaded for chemotherapy. Moreover, due to the two-photon excited fluorescence of SiNPs, the nanocomposite successfully achieved targeted two-photon fluorescence cellular imaging at the near-infrared (NIR) laser excitation, which could effectively avoid the interference of biological auto-fluorescence. And in vitro cytotoxicity assays revealed that the synergistic therapy combining PDT and chemotherapy exhibited high therapeutic efficacy for cancer cells.

Cupredoxin engineered upconversion nanoparticles for ratiometric luminescence sensing of Cu2

The NIR excitation and large anti-Stokes shift of upconversion nanoparticles (UCNPs) have made them an ideal choice as biological nanoprobes. A key challenge in the field is to confer biorecognition units to UCNPs so that they can be used to probe specific targets in biological systems. While various agents have been combined with UCNPs to meet such a challenge, most studies are limited to small molecules, while biomolecules such as metalloproteins that possess much higher affinity and selectivity for metal ions have not been explored. Herein we demonstrate that fusion of zwitterion-coated UCNPs with azurin, a member of a family of redox-active copper proteins called cupredoxins that play important roles in diverse biological functions, can serve as an ideal platform for the label-free upconversion luminescence sensing of Cu2+ with a ratiometric response. The selectively binding of apo-azurin with Cu2+ induce a significant absorbance at about 625 nm, and hence decreases the red emission of the UCNPs. In contrast, the green emission of the UCNPs remains constant and acts as an internal standard reference for the ratiometric sensing of Cu2+. This approach opens a new window for the development of assays for biosensing based on a combination of specific metalloproteins with UCNPs.

Advances in nanomaterials for use in photothermal and photodynamic therapeutics (Review)

Nanomaterials play crucial roles in the diagnosis and treatment of diseases. Photothermal and photodynamic therapy, as two minimally invasive therapeutic methods, have promising potential in the diagnosis and prevention of cancer. Recently, many photothermal materials (such as noble metal material, transition metal sulfur oxides, carbon material and upconversion nanomaterial) and photodynamic materials (such as phthalein cyanogen, porphyrins and other dye molecules) have been applied in photothermal therapy (PTT) and photodynamic therapy (PDT). Moreover, as nanomaterials have suitable biocompatibility, these materials have been applied in cancer therapy. In the present review, we summarized the effects of different material types, synthesis methods, material morphologies and surface modifications on the outcomes of cancer therapy. The application of nanomaterials in PTT and PDT was introduced and the advantages and disadvantages of PTT and PDT in the prevention of cancer were discussed. Finally, we discussed the application of nanomaterials in the combination of PTT and PDT in cancer treatment.

Real-time monitoring of pH-responsive drug release using a metal-phenolic network-functionalized upconversion nanoconstruct

Smart drug delivery nanosystems with integrated real-time monitoring capability have attracted great attention in recent years; however, they are still in a nascent stage due to a lack of proper imaging modalities. Herein, we present a novel pH-responsive drug delivery nanosystem in which a coordination complex of tannic acid and Cu2+ ions was successfully functionalized onto the surface of mesoporous silica-coated upconversion nanoparticles (UCNPs) to block premature release of the anti-cancer drug doxorubicin (DOX) from the mesopores of the particles. In addition, loading of the drug enables luminescence resonance energy transfer (LRET) from the UCNPs to DOX, which results in quenching of the emission of the UCNPs. The metal-phenolic networks are degraded in the acidic environment in living cells, leading to DOX release from the mesopores and thus to elimination of LRET. Therefore, the changes in upconversion luminescence enable monitoring of the pH-triggered drug release in real-time. This strategy will facilitate the design of smart drug delivery systems and theranostics.

Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics

Copper sulfide nanoparticles (CuS NPs), emerging nanoplatforms with dual diagnostic and therapeutic applications, are being actively investigated in this era of "war on cancer" owing to their versatility and adaptability. This article discusses the pros and cons of using CuS NPs in diagnostics, therapeutics, and theranostics. The first section introduces CuS NPs and discusses the features that render them more advantageous than other established nanoplatforms in cancer management. Subsequent sections include specific in vitro and in vivo results of different studies showing the potential of CuS NPs as nanoplatforms. Methods used for visualization (photoacoustic imaging and magnetic resonance imaging) of CuS NPs and treatment (phototherapy and combinatorial therapy) have also been discussed. Furthermore, the challenges and opportunities associated with using CuS NPs have been elucidated. Further investigations on CuS NPs are required to translate it for clinical applications.

The effect of low- and high-penetration light on localized cancer therapy

The design of a delivery system allowing targeted and controlled drug release has been considered one of the main strategies used to provide individualized cancer therapy, to improve survival statistics, and to enhance quality-of-life. External stimuli including low- and high-penetration light have been shown to have the ability to turn drug delivery on and off in a non-invasive remotely-controlled fashion. The success of this approach has been closely related to the development of a variety of drug delivery systems - from photosensitive liposomes to gold nanocages - and relies on multiple mechanisms of drug release activation. In this review, we make reference to the two extremes of the light spectrum and their potential as triggers for the delivery of antitumor drugs, along with the most recent achievements in preclinical trials and the challenges to an efficient translation of this technology to the clinical setting.

Upconverting LuVO4:Nd3+/Yb3+/Er3+@SiO2@Cu2S Hollow Nanoplatforms for Self-monitored Photothermal Ablation

Self-monitored photothermal therapy (PTT) with minimal collateral damages has emerged as a challenging strategy for antibacterial and cancer treatments, which could be fulfilled via the rational integration of luminescent thermometry and photothermal ablation within a single upconverting (UC) nanoplatform. Herein, 808 nm light-driven dual-functional nanoplatforms LuVO₄:Nd³⁺/Yb³⁺/Er³⁺@SiO₂@Cu₂S were successfully developed using olivelike LuVO₄:Nd³⁺/Yb³⁺/Er³⁺ hollow nanoparticles as the thermal-sensing core and ultrasmall Cu₂S nanoparticles as the photothermal satellite. Irradiated by 808 nm laser, thermal-sensing behaviors of samples were evaluated based on the high-purity Er³⁺ green emissions, while the surface-attached Cu₂S exhibited superior photothermal effects due to the efficient absorption of incident laser and near-infrared emissions from the luminescent core. The feasibility of bifunctional samples acting as self-monitored photothermal agents in subtissues and antibacterial agents against drug-resistant bacteria was separately assessed. Results provide deeper insights into the desirable design of 808 nm-driven multifunctional nanoplatforms with intense UC emission, sensitive thermometry, and effective photothermal conversion toward self-monitored PTT with high therapeutic accuracy.

Reduction-sensitive polypeptide nanogel conjugated BODIPY-Br for NIR imaging-guided chem/photodynamic therapy at low light and drug dose

A heavy atoms modified reaction-active photosensitizer NHS-BODIPY-Br possessing efficient near infrared (NIR) fluorescence emission and singlet oxygen generation properties has been synthesized, which can be used for synchronous NIR imaging and photodynamic therapy (PDT). A reduction-sensitive PEGylated polypeptide nanogel was prepared by ring-opening polymerization (ROP) of l-cystine-N-carboxy anhydride. Poly (ethylene glycol) methyl ether was used as initiator and hydrophilic segment, the as-prepared nanogel was conjugated with the NHS-BODIPY-Br molecule by chemical linkage, and it can be directly used as a macrophotosentizer for NIR imaging-guided PDT. In addition, the nanogel also showed good encapsulating ability for doxorubicin (DOX). In the presence of glutathione (10 mM), the obtained NIR nanogel showed obvious reduction-induced drug release behavior. In vitro tests on internalization of the NIR nanogel by HepG2 cells indicated its efficiency in detecting cancer cells. Meanwhile, MTT assays performed on HepG2 cells confirmed that the cancer cells growth could be obviously suppressed (almost all cells) when exposed to an extremely low energy light (25 mW/cm², 10-15 J/cm²) and low dose of DOX (3-5 μg/ml), indicates an efficient NIR image-guided chem/photodynamic therapy.

Se@SiO2-FA-CuS nanocomposites for targeted delivery of DOX and nano selenium in synergistic combination of chemo-photothermal therapy

In this study, a versatile tumor-targeted and multi-stimuli-responsive drug delivery vehicle (Se particle@porous silica-folic acid-copper sulfide/doxorubicin (Se@SiO₂-FA-CuS/DOX)) was fabricated for combined photothermal therapy with chemotherapy in cancer treatment. Due to excellent targeting ability, the Se@SiO₂-FA-CuS/DOX nanocomposites actively accumulated in tumor tissues and thus provided photothermal therapy under NIR irradiation and chemotherapy through the release of DOX and Se. Owing to the synergistic effect of chemotherapy (Se and DOX) and photothermal therapy, the Se@SiO₂-FA-CuS/DOX nanocomposites could efficiently inhibit cancer cells both in vitro and in vivo and even completely eliminate tumors. Moreover, as the toxicity of DOX could be reduced by Se, the treatment using Se@SiO₂-FA-CuS/DOX nanocomposites exhibited no appreciable adverse reactions. Thus, the Se@SiO₂-FA-CuS/DOX nanocomposites have great potential as a multifunctional nanoplatform in future clinical applications.

Theranostic nanocomposite from upconversion luminescent nanoparticles and black phosphorus nanosheets

An anti-cancer campaign might not be easily achieved through a single therapeutic modality. Collaboration of multimodal therapies and diagnosis could be vital to win the battle against cancer. In this context, we synthesized a multifunctional theranostic nanocomposite (UCNP–BPNS) from upconversion nanoparticles (UCNP) and black phosphorus nanosheets (BPNS) for synergistic photothermal/photodynamic therapies in vitro and dual modal imaging. Core–shell UCNP (NaYF₄:Yb,Er@NaGdF₄) and BPNS were synthesized using solvo-thermal and liquid exfoliation methods, respectively, and then covalently conjugated after UCNP was modified with polyacrylic acid and BPNS with methoxypolyethylene glycol amine. The experimental results validate that the nanocomposite exhibited a good photothermal therapy (PTT) effect under 808 nm laser irradiation, endorsing the apparent heat conversion effect of BPNS. Besides, a very good photodynamic therapy (PDT) effect was achieved under 980 nm laser irradiation of the nanocomposite due to Förster resonance energy transfer from UCNP to BPNS that generated singlet oxygen (¹O₂). The synergistic PTT/PDT therapeutic effect provided by UCNP–BPNS under simultaneous 808 and 980 nm laser irradiation was significantly higher than either PTT or PDT alone. Furthermore, due to the merit of the outer shell coated on the surface of the core of UCNP, the nanocomposite exhibited good potential for magnetic resonance and upconversion luminescence imaging. These results demonstrated that our multifunctional nanocomposite has promising theranostic efficacy under near infrared laser irradiation.

We successfully synthesized a multifunctional theranostic nanocomposite from upconversion nanoparticles and black phosphorus nanosheets for synergistic photothermal/photodynamic therapies in vitro and dual modal imaging.

Mesoporous silica nanoparticles in recent photodynamic therapy applications

In this review, the use of mesoporous silica nanoparticles for photodynamic therapy (PDT) applications is described for the year 2017.

Enhanced reactive oxygen species through direct copper sulfide nanoparticle-doxorubicin complexation

CuS-based nanostructures loading the chemotherapeutic agent doxorubicin (DOX) exerted excellent cancer photothermal chemotherapy under multi-external stimuli. The DOX loading was generally designed through electrostatic interaction or chemical linkers. However, the interaction between DOX molecules and CuS nanoparticles has not been investigated. In this work, we use PEGylated hollow copper sulfide nanoparticles (HCuSNPs) to directly load DOX through the DOX/Cu²⁺ chelation process. Distinctively, the synthesized PEG-HCuSNPs-DOX release the DOX/Cu²⁺ complexes into surrounding environment, which generate significant reactive oxygen species (ROS) in a controlled manner by near-infrared laser. The CuS nanoparticle-mediated photothermal ablation facilitates the ROS-induced cancer cell killing effect. Our current work reveals a DOX/Cu²⁺-mediated ROS-enhanced cell-killing effect in addition to conventional photothermal chemotherapy through the direct CuS nanoparticle-DOX complexation.

Facile Synthesis of Lanthanide (Ce, Eu, Tb, Ce/Tb, Yb/Er, Yb/Ho, and Yb/Tm)-Doped LnF3 and LnOF Porous Sub-Microspheres with Multicolor Emissions

Monodisperse YF₃ and YOF porous sub-microspheres were synthesized by using a novel sacrificing template method with amorphous Y(OH)CO₃ ⋅x H₂ O as the precursors and the template. It was found that the size and shape were well maintained, and the condensed precursor was transformed into uniform porous structures after fluoridation. By fine-tuning the feed of the fluorine source, the final product could be converted from YF₃ to YOF. A possible growth mechanism is proposed for the uniform porous YF₃ structure and the porous yolk-shell-like YOF structure. The luminescence properties showed that the as-synthesized YF₃ :Ln³⁺ (Ln=Eu, Tb, Ce, Ce/Tb, Yb/Er, Yb/Ho, and Yb/Tm) products exhibited strong multicolor emissions, which included down-/upconversion and energy-transfer processes. Additionally, YOX (X=Cl and Br) could be obtained if a different halogen source was used during calcination. However, the spheres were almost completely destroyed. Our novel synthetic route can also be extended to other lanthanide fluorides (REF₃ , RE=Gd, Lu), which may open a facile way to fabricate novel porous nanostructures.

Phthalocyanine-based coordination polymer nanoparticles for enhanced photodynamic therapy

In the photodynamic therapy (PDT) of cancer, zinc phthalocyanine (ZnPc) as a photosensitizer possesses superior photosensitive properties. However, the therapeutic effect of ZnPc in PDT is limited due to its aggregation, low solubility and poor selectivity. In this study, charge-reversal phthalocyanine-based coordination polymer nanoparticles (PCPN) are developed for improving the curative effect of ZnPc. Tetra(4-carboxyphenoxy)-phthalocyaninatozinc(ii) (TPZnPc) is coordinated with the zinc ion to form the core of PCPN, which is coated with a lipid bilayer by self-assembly (PCPNs@Lip). TPZnPc molecules in the core of PCPN are in the monomeric state and can generate cytotoxic singlet oxygen (¹O₂) efficiently, which solves the solubility and aggregation problems of ZnPc. Meanwhile, 1,2-dicarboxylic-cyclohexane anhydride modified lysyl-cholesterol (DLC) is functionalized on the surface of PCPN (PCPNs@Lip/DLC), endowing PCPN with a charge-reversal ability which could be triggered by a mildly acidic tumor microenvironment. PCPNs@Lip/DLC is proved to enhance tumor cellular uptake and generate more intracellular ¹O₂ after irradiation. As confirmed by in vitro and in vivo studies, PCPNs@Lip/DLC remarkably increases the PDT effect. All these results demonstrate that PCPNs@Lip/DLC is a promising nanoplatform for the application of ZnPc in effective PDT.

Photochemistry and Photophysics in Silica-Based Materials: Ultrafast and Single Molecule Spectroscopy Observation

Silica-based materials (SBMs) are widely used in catalysis, photonics, and drug delivery. Their pores and cavities act as hosts of diverse guests ranging from classical dyes to drugs and quantum dots, allowing changes in the photochemical behavior of the confined guests. The heterogeneity of the guest populations as well as the confinement provided by these hosts affect the behavior of the formed hybrid materials. As a consequence, the observed reaction dynamics becomes significantly different and complex. Studying their photobehavior requires advanced laser-based spectroscopy and microscopy techniques as well as computational methods. Thanks to the development of ultrafast (spectroscopy and imaging) tools, we are witnessing an increasing interest of the scientific community to explore the intimate photobehavior of these composites. Here, we review the recent theoretical and ultrafast experimental studies of their photodynamics and discuss the results in comparison to those in homogeneous media. The discussion of the confined dynamics includes solvation and intra- and intermolecular proton-, electron-, and energy transfer events of the guest within the SBMs. Several examples of applications in photocatalysis, (photo)sensors, photonics, photovoltaics, and drug delivery demonstrate the vast potential of the SBMs in modern science and technology.

Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents

Photodynamic therapy (PDT) is an established method for the treatment of cancer which utilizes light, a photosensitizer (PS), and oxygen. Unfavourable characteristics of most PSs, such as low solubility and tumour specificity have led many researchers to adopt nanoscale drug delivery platforms for use in PDT. Mesoporous silica nanoparticles (MSNs) form a significant part of that effort, due to their ease and controllability of synthesis, ease of loading, availability of diverse surface functionalization, and biocompatibility. Therefore, in this review, we discuss the properties of MSNs as they pertain to their use in PDT and review the latest advances in the field, comparing the different approaches currently being used.

Controlled synthesis of upconverting nanoparticles/CuS yolk–shell nanoparticles for in vitro synergistic photothermal and photodynamic therapy of cancer cells

A chemical solution method involving multistep process has been developed to fabricate UCNPs@CuS yolk–shell nanoparticles for synergistic photothermal and photodynamic therapy of cancer cells.